Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
Boehringer touts promising launches of Hernexeos, Jascayd
Without reporting sales figures, Boehringer Ingelheim touted its promising launches of lung disease drug Jascayd and lung cancer therapy Hernexeos.
Kevin Dunleavy
Mar 25, 2026 10:57am
WuXi Bio's contracting business saw influx of US clients in '25
Mar 24, 2026 10:56am
Patent expirations push biopharma industry toward a tougher 2026
Mar 13, 2026 9:49am
Galderma doubles Nemluvio peak sales outlook to $4B-plus
Mar 5, 2026 11:20am
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
BioMarin pulls gene therapy Roctavian off the market
Feb 24, 2026 12:30pm
